Ashok Talreja, MD
Clinical Cardiac Electrophysiology · Fredericksburg, VANPI 1457416794
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 66.4% of it on its own, with 28 other manufacturers making up the rest. 2025 is the largest year on record at $8,062, 2.1 times the $3,894 reported in 2019.
Across 524 payments — averaging $61.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$21K
- Boston Scientific$2K
- Medical Device Business Services, Inc.$2K
- Abbott$2K
- Biosense Webster, Inc.$1K
- Biotronik Inc.$582
- plus $2K from 23 others
Across 29 payments — averaging $1054.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$21K
- Boston Scientific$7K
- Biotronik Inc.$3K
What the payments were for
- Consulting fees$15,00047%
- Travel & lodging$6,83021%
- Food & beverage$10,30132%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 272 | $21,344 |
| Boston Scientific | 29 | $2,467 |
| Medical Device Business Services, Inc. | 8 | $2,362 |
| Abbott | 38 | $1,916 |
| Biosense Webster, Inc. | 43 | $1,059 |
| Biotronik Inc. | 8 | $582 |
| Novartis | 29 | $438 |
| Johnson & Johnson | 23 | $389 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $172 |
| Merck | 8 | $159 |
| Atricure, Inc. | 5 | $158 |
| E.r. Squibb & Sons, L.L.C. | 8 | $138 |
| Coala Life Inc | 4 | $135 |
| Pfizer | 7 | $117 |
| AstraZeneca | 6 | $116 |
| Cardiva Medical, Inc. | 4 | $88 |
| Penumbra, Inc. | 3 | $71 |
| Impulse Dynamics (USA) Inc. | 1 | $53 |
| Baxter Healthcare | 1 | $52 |
| Philips North America LLC | 3 | $49 |
| Sanofi-aventis U.S. LLC | 2 | $42 |
| Medicomp Inc | 2 | $40 |
| Amgen | 2 | $40 |
| Kestra Medical Technology Services, Inc. | 2 | $32 |
| Cordis US CORP. | 1 | $27 |
| Vifor Pharma, Inc. | 2 | $25 |
| ZOLL Circulation Inc | 1 | $25 |
| Novo Nordisk | 1 | $18 |
| Elutia, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$2,579
- WATCHMAN Access System$1,250
- EVERA MRI XT DR SURESCAN$955
- AVEIR$852
- PulseSelect$267
- COREVALVE EVOLUT R$262
- WATCHMAN FLX$137
- AXIOS$129
- CardioMEMS HF System$129
- XARELTO$118
- AFFERA MAPPING SYSTEM$108
How this compares
$32,131 in reported general payments places this provider in the 65th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
See all clinical cardiac electrophysiology providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 141 | $145,960 |
| XareltoRivaroxaban | 35 | $39,761 |
| EntrestoSacubitril/Valsartan | 33 | $27,393 |
| MultaqDronedarone Hcl | 11 | $20,946 |
| Metoprolol Succinate | 142 | $2,900 |
| Flecainide Acetate | 48 | $2,012 |
| Amiodarone Hcl | 76 | $1,439 |
| Bumetanide | 27 | $1,010 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 26 | $947 |
| Rosuvastatin Calcium | 50 | $823 |
| Carvedilol | 80 | $772 |
| Potassium Chloride | 12 | $577 |
| Losartan Potassium | 56 | $459 |
| Atorvastatin Calcium | 58 | $411 |
| Propranolol Hcl ErPropranolol Hcl | 12 | $404 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $117 | $145,960141 claims |
| Johnson & JohnsonXarelto | $389 | $39,76135 claims |
| NovartisEntresto | $438 | $27,39333 claims |
| Sanofi-aventis U.S. LLCMultaq | $42 | $20,94611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
Other clinical cardiac electrophysiology in Fredericksburg
- Peem LorvidhayaFredericksburg$230K
- Hakeem AyindeFredericksburg$26K
- Kenneth EllenbogenRichmond$360K
- Brett AtwaterFairfax$319K
- Oliver MonfrediCharlottesville$231K
- Erich KiehlNewport News$181K
- Emmanuel EkanemWinchester$132K
- Pamela MasonCharlottesville$130K
- Ajay PillaiRichmond$129K
- Stephen GaetaFairfax$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.